Global Oncology Academy

Managing Immunotherapy Toxicities in Lung Cancer Patients 

ReachMD Healthcare Image
RestartResume

Lung cancer patients undergoing immunotherapy may be at risk for developing life-threatening toxicities. Here’s how we can manage them.

  • Overview

    Lung cancer patients undergoing immunotherapy may be at risk for developing life-threatening toxicities. Find out how you can manage them with Dr. Jacob Sands and Dr. Aliyah Pabani, Clinical Assistant Professor in the Department of Medicine at the University of Calgary and Director of the Alberta Immunotherapy Database.  

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free